We've found
7,711
archived clinical trials in
Depression
We've found
7,711
archived clinical trials in
Depression
Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence
Updated: 3/21/2016
Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence
Status: Enrolling
Updated: 3/21/2016
Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence
Updated: 3/21/2016
Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence
Status: Enrolling
Updated: 3/21/2016
Click here to add this to my saved trials
A Randomized Controlled Trial of In-Home Tele-Behavioral Health Care Utilizing Behavioral Activation for Depression
Updated: 3/21/2016
A Randomized Controlled Trial of In-Home Tele-behavioral Health Care Utilizing Behavioral Activation for Depression
Status: Enrolling
Updated: 3/21/2016
A Randomized Controlled Trial of In-Home Tele-Behavioral Health Care Utilizing Behavioral Activation for Depression
Updated: 3/21/2016
A Randomized Controlled Trial of In-Home Tele-behavioral Health Care Utilizing Behavioral Activation for Depression
Status: Enrolling
Updated: 3/21/2016
Click here to add this to my saved trials
A Randomized Controlled Trial of In-Home Tele-Behavioral Health Care Utilizing Behavioral Activation for Depression
Updated: 3/21/2016
A Randomized Controlled Trial of In-Home Tele-behavioral Health Care Utilizing Behavioral Activation for Depression
Status: Enrolling
Updated: 3/21/2016
A Randomized Controlled Trial of In-Home Tele-Behavioral Health Care Utilizing Behavioral Activation for Depression
Updated: 3/21/2016
A Randomized Controlled Trial of In-Home Tele-behavioral Health Care Utilizing Behavioral Activation for Depression
Status: Enrolling
Updated: 3/21/2016
Click here to add this to my saved trials
Seroquel Alone Versus Seroquel With an SSRI for Depression With Psychotic Symptoms
Updated: 3/25/2016
The Efficacy and Tolerability of Seroquel XR Combined With a Selective Serotonin Re-Uptake Inhibitor Versus Seroquel XR Monotherapy in the Acute Treatment of Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/25/2016
Seroquel Alone Versus Seroquel With an SSRI for Depression With Psychotic Symptoms
Updated: 3/25/2016
The Efficacy and Tolerability of Seroquel XR Combined With a Selective Serotonin Re-Uptake Inhibitor Versus Seroquel XR Monotherapy in the Acute Treatment of Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/25/2016
Click here to add this to my saved trials
Efficacy of an Exercise Intervention to Decrease Depressive Symptoms in Veterans With Hepatitis C
Updated: 3/28/2016
Efficacy of an Exercise Intervention to Decrease Depressive Symptoms in Veterans With Hepatitis C
Status: Enrolling
Updated: 3/28/2016
Efficacy of an Exercise Intervention to Decrease Depressive Symptoms in Veterans With Hepatitis C
Updated: 3/28/2016
Efficacy of an Exercise Intervention to Decrease Depressive Symptoms in Veterans With Hepatitis C
Status: Enrolling
Updated: 3/28/2016
Click here to add this to my saved trials
Effectiveness of Sertraline Alone and Interpersonal Psychotherapy Alone in Treating Women With Postpartum Depression
Updated: 3/29/2016
Placebo Controlled Trial of Sertraline and Interpersonal Psycho-Therapy for Postpartum Depression
Status: Enrolling
Updated: 3/29/2016
Effectiveness of Sertraline Alone and Interpersonal Psychotherapy Alone in Treating Women With Postpartum Depression
Updated: 3/29/2016
Placebo Controlled Trial of Sertraline and Interpersonal Psycho-Therapy for Postpartum Depression
Status: Enrolling
Updated: 3/29/2016
Click here to add this to my saved trials
Effectiveness of Sertraline Alone and Interpersonal Psychotherapy Alone in Treating Women With Postpartum Depression
Updated: 3/29/2016
Placebo Controlled Trial of Sertraline and Interpersonal Psycho-Therapy for Postpartum Depression
Status: Enrolling
Updated: 3/29/2016
Effectiveness of Sertraline Alone and Interpersonal Psychotherapy Alone in Treating Women With Postpartum Depression
Updated: 3/29/2016
Placebo Controlled Trial of Sertraline and Interpersonal Psycho-Therapy for Postpartum Depression
Status: Enrolling
Updated: 3/29/2016
Click here to add this to my saved trials
Sober Network IPT for Perinatal Women With Comorbid Substance Use and Depression
Updated: 3/29/2016
Sober Network IPT for Perinatal Women With Comorbid Substance Use and Depression
Status: Enrolling
Updated: 3/29/2016
Sober Network IPT for Perinatal Women With Comorbid Substance Use and Depression
Updated: 3/29/2016
Sober Network IPT for Perinatal Women With Comorbid Substance Use and Depression
Status: Enrolling
Updated: 3/29/2016
Click here to add this to my saved trials
Role of Exercise in Depression in Middle Aged and Older Adults
Updated: 3/31/2016
Role of Exercise in Depression Among Middle Aged and Older Adults
Status: Enrolling
Updated: 3/31/2016
Role of Exercise in Depression in Middle Aged and Older Adults
Updated: 3/31/2016
Role of Exercise in Depression Among Middle Aged and Older Adults
Status: Enrolling
Updated: 3/31/2016
Click here to add this to my saved trials
Addressing Mental Health in African American Job Training Adolescents and Young Adults
Updated: 4/5/2016
Addressing Mental Health in African American Job Training Adolescents and Young Adults
Status: Enrolling
Updated: 4/5/2016
Addressing Mental Health in African American Job Training Adolescents and Young Adults
Updated: 4/5/2016
Addressing Mental Health in African American Job Training Adolescents and Young Adults
Status: Enrolling
Updated: 4/5/2016
Click here to add this to my saved trials
VA Home-Based Emotional Learning With Practical Skills
Updated: 4/5/2016
VA Home-Based Emotional Learning With Practical Skills (VA-HELPS): Treatment for Depressed and/or Anxious Rural Veterans in Home-Based Primary Care
Status: Enrolling
Updated: 4/5/2016
VA Home-Based Emotional Learning With Practical Skills
Updated: 4/5/2016
VA Home-Based Emotional Learning With Practical Skills (VA-HELPS): Treatment for Depressed and/or Anxious Rural Veterans in Home-Based Primary Care
Status: Enrolling
Updated: 4/5/2016
Click here to add this to my saved trials
Efficacy of Adjunctive Exercise for the Behavioral Treatment of Major Depression
Updated: 4/5/2016
Efficacy of Adjunctive Exercise for the Behavioral Treatment of Major Depression
Status: Enrolling
Updated: 4/5/2016
Efficacy of Adjunctive Exercise for the Behavioral Treatment of Major Depression
Updated: 4/5/2016
Efficacy of Adjunctive Exercise for the Behavioral Treatment of Major Depression
Status: Enrolling
Updated: 4/5/2016
Click here to add this to my saved trials
Preventing Postpartum Depression in African American Home Visiting Clients
Status: Enrolling
Updated: 4/5/2016
Updated: 4/5/2016
Preventing Postpartum Depression in African American Home Visiting Clients
Status: Enrolling
Updated: 4/5/2016
Updated: 4/5/2016
Click here to add this to my saved trials
Preventing Postpartum Depression in African American Home Visiting Clients
Status: Enrolling
Updated: 4/5/2016
Updated: 4/5/2016
Preventing Postpartum Depression in African American Home Visiting Clients
Status: Enrolling
Updated: 4/5/2016
Updated: 4/5/2016
Click here to add this to my saved trials
Preventing Postpartum Depression in African American Home Visiting Clients
Status: Enrolling
Updated: 4/5/2016
Updated: 4/5/2016
Preventing Postpartum Depression in African American Home Visiting Clients
Status: Enrolling
Updated: 4/5/2016
Updated: 4/5/2016
Click here to add this to my saved trials
Preventing Postpartum Depression in African American Home Visiting Clients
Status: Enrolling
Updated: 4/5/2016
Updated: 4/5/2016
Preventing Postpartum Depression in African American Home Visiting Clients
Status: Enrolling
Updated: 4/5/2016
Updated: 4/5/2016
Click here to add this to my saved trials
Perimenopausal Estrogen Replacement Therapy Study
Updated: 4/6/2016
Depression, Estrogen Replacement, and Cardiovascular Health in the Perimenopause
Status: Enrolling
Updated: 4/6/2016
Perimenopausal Estrogen Replacement Therapy Study
Updated: 4/6/2016
Depression, Estrogen Replacement, and Cardiovascular Health in the Perimenopause
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials
Phenotype Depression Study
Updated: 4/7/2016
Phenotyping Major Depression With Increased Inflammation
Status: Enrolling
Updated: 4/7/2016
Phenotype Depression Study
Updated: 4/7/2016
Phenotyping Major Depression With Increased Inflammation
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Brief Cognitive Behavioral Therapy (CBT) for Pediatric Anxiety and Depression in Primary Care
Updated: 4/12/2016
Brief CBT for Pediatric Anxiety and Depression in Primary Care
Status: Enrolling
Updated: 4/12/2016
Brief Cognitive Behavioral Therapy (CBT) for Pediatric Anxiety and Depression in Primary Care
Updated: 4/12/2016
Brief CBT for Pediatric Anxiety and Depression in Primary Care
Status: Enrolling
Updated: 4/12/2016
Click here to add this to my saved trials
Brief Cognitive Behavioral Therapy (CBT) for Pediatric Anxiety and Depression in Primary Care
Updated: 4/12/2016
Brief CBT for Pediatric Anxiety and Depression in Primary Care
Status: Enrolling
Updated: 4/12/2016
Brief Cognitive Behavioral Therapy (CBT) for Pediatric Anxiety and Depression in Primary Care
Updated: 4/12/2016
Brief CBT for Pediatric Anxiety and Depression in Primary Care
Status: Enrolling
Updated: 4/12/2016
Click here to add this to my saved trials
Holistic Approaches to Depression
Updated: 4/12/2016
Holistic Approaches to Depression
Status: Enrolling
Updated: 4/12/2016
Holistic Approaches to Depression
Updated: 4/12/2016
Holistic Approaches to Depression
Status: Enrolling
Updated: 4/12/2016
Click here to add this to my saved trials
Low Field Magnetic Stimulation (LFMS) in Mood Disorders: 6 Treatments
Updated: 4/12/2016
Low Field Magnetic Stimulation in Mood Disorders in Six Visits
Status: Enrolling
Updated: 4/12/2016
Low Field Magnetic Stimulation (LFMS) in Mood Disorders: 6 Treatments
Updated: 4/12/2016
Low Field Magnetic Stimulation in Mood Disorders in Six Visits
Status: Enrolling
Updated: 4/12/2016
Click here to add this to my saved trials
Efficacy of TDCS for Treating Working Memory Dysfunction and Depression in Temporal Lobe Epilepsy
Updated: 4/13/2016
Efficacy of Transcranial Direct Current Stimulation for Treating Working Memory Dysfunction and Depression For Patients With Temporal Lobe Epilepsy
Status: Enrolling
Updated: 4/13/2016
Efficacy of TDCS for Treating Working Memory Dysfunction and Depression in Temporal Lobe Epilepsy
Updated: 4/13/2016
Efficacy of Transcranial Direct Current Stimulation for Treating Working Memory Dysfunction and Depression For Patients With Temporal Lobe Epilepsy
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Expressive Writing for Reducing Stress and Diabetic Symptoms in Diabetes Patients
Updated: 4/13/2016
Expressive Writing: Complementary Treatment for Diabetes
Status: Enrolling
Updated: 4/13/2016
Expressive Writing for Reducing Stress and Diabetic Symptoms in Diabetes Patients
Updated: 4/13/2016
Expressive Writing: Complementary Treatment for Diabetes
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Expressive Writing for Reducing Stress and Diabetic Symptoms in Diabetes Patients
Updated: 4/13/2016
Expressive Writing: Complementary Treatment for Diabetes
Status: Enrolling
Updated: 4/13/2016
Expressive Writing for Reducing Stress and Diabetic Symptoms in Diabetes Patients
Updated: 4/13/2016
Expressive Writing: Complementary Treatment for Diabetes
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Expressive Writing for Reducing Stress and Diabetic Symptoms in Diabetes Patients
Updated: 4/13/2016
Expressive Writing: Complementary Treatment for Diabetes
Status: Enrolling
Updated: 4/13/2016
Expressive Writing for Reducing Stress and Diabetic Symptoms in Diabetes Patients
Updated: 4/13/2016
Expressive Writing: Complementary Treatment for Diabetes
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Expressive Writing for Reducing Stress and Diabetic Symptoms in Diabetes Patients
Updated: 4/13/2016
Expressive Writing: Complementary Treatment for Diabetes
Status: Enrolling
Updated: 4/13/2016
Expressive Writing for Reducing Stress and Diabetic Symptoms in Diabetes Patients
Updated: 4/13/2016
Expressive Writing: Complementary Treatment for Diabetes
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Prolonging Remission in Depressed Elderly (PRIDE)
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Status: Enrolling
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
Prolonging Remission in Depressed Elderly (PRIDE)
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Status: Enrolling
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
Prolonging Remission in Depressed Elderly (PRIDE)
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Status: Enrolling
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
Prolonging Remission in Depressed Elderly (PRIDE)
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Status: Enrolling
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
Prolonging Remission in Depressed Elderly (PRIDE)
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Status: Enrolling
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
Prolonging Remission in Depressed Elderly (PRIDE)
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Status: Enrolling
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
Prolonging Remission in Depressed Elderly (PRIDE)
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Status: Enrolling
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
Prolonging Remission in Depressed Elderly (PRIDE)
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Status: Enrolling
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
Prolonging Remission in Depressed Elderly (PRIDE)
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Status: Enrolling
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
Prolonging Remission in Depressed Elderly (PRIDE)
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Status: Enrolling
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Updated: 4/18/2016
Prolonging Remission in Depressed Elderly (PRIDE)
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
Trial of a Positive Psychology Intervention in Major Depressive Disorder
Updated: 4/18/2016
Trial of a Positive Psychology Intervention to Reduce Suicide Risk in Patients With Major Depression
Status: Enrolling
Updated: 4/18/2016
Trial of a Positive Psychology Intervention in Major Depressive Disorder
Updated: 4/18/2016
Trial of a Positive Psychology Intervention to Reduce Suicide Risk in Patients With Major Depression
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
Double-Blind Treatment of Major Depressive Disorder With Vilazodone
Updated: 4/19/2016
Double-Blind Switch Study of Vilazodone in the Treatment of Major Depressive Disorder Following Partial Response to or Inability to Tolerate a Generic SSRI
Status: Enrolling
Updated: 4/19/2016
Double-Blind Treatment of Major Depressive Disorder With Vilazodone
Updated: 4/19/2016
Double-Blind Switch Study of Vilazodone in the Treatment of Major Depressive Disorder Following Partial Response to or Inability to Tolerate a Generic SSRI
Status: Enrolling
Updated: 4/19/2016
Click here to add this to my saved trials
Mother-Infant Intervention for Postpartum Depression and Associated Mother-Infant Relationship Dysfunction
Updated: 4/19/2016
Dyadic Intervention for Women at Risk for Postpartum Depression and Their Infants
Status: Enrolling
Updated: 4/19/2016
Mother-Infant Intervention for Postpartum Depression and Associated Mother-Infant Relationship Dysfunction
Updated: 4/19/2016
Dyadic Intervention for Women at Risk for Postpartum Depression and Their Infants
Status: Enrolling
Updated: 4/19/2016
Click here to add this to my saved trials
Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Updated: 4/25/2016
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Long-term Study to Evaluate the Maintenance of Efficacy and Safety of 1 to 3 mg/Day of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 4/25/2016
Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Updated: 4/25/2016
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Long-term Study to Evaluate the Maintenance of Efficacy and Safety of 1 to 3 mg/Day of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 4/25/2016
Click here to add this to my saved trials
Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Updated: 4/25/2016
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Long-term Study to Evaluate the Maintenance of Efficacy and Safety of 1 to 3 mg/Day of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 4/25/2016
Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Updated: 4/25/2016
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Long-term Study to Evaluate the Maintenance of Efficacy and Safety of 1 to 3 mg/Day of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 4/25/2016
Click here to add this to my saved trials
Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Updated: 4/25/2016
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Long-term Study to Evaluate the Maintenance of Efficacy and Safety of 1 to 3 mg/Day of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 4/25/2016
Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Updated: 4/25/2016
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Long-term Study to Evaluate the Maintenance of Efficacy and Safety of 1 to 3 mg/Day of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 4/25/2016
Click here to add this to my saved trials
Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Updated: 4/25/2016
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Long-term Study to Evaluate the Maintenance of Efficacy and Safety of 1 to 3 mg/Day of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 4/25/2016
Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Updated: 4/25/2016
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Long-term Study to Evaluate the Maintenance of Efficacy and Safety of 1 to 3 mg/Day of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 4/25/2016
Click here to add this to my saved trials
Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Updated: 4/25/2016
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Long-term Study to Evaluate the Maintenance of Efficacy and Safety of 1 to 3 mg/Day of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 4/25/2016
Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Updated: 4/25/2016
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Long-term Study to Evaluate the Maintenance of Efficacy and Safety of 1 to 3 mg/Day of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 4/25/2016
Click here to add this to my saved trials
Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Updated: 4/25/2016
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Long-term Study to Evaluate the Maintenance of Efficacy and Safety of 1 to 3 mg/Day of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 4/25/2016
Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Updated: 4/25/2016
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Long-term Study to Evaluate the Maintenance of Efficacy and Safety of 1 to 3 mg/Day of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 4/25/2016
Click here to add this to my saved trials
Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Updated: 4/25/2016
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Long-term Study to Evaluate the Maintenance of Efficacy and Safety of 1 to 3 mg/Day of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 4/25/2016
Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Updated: 4/25/2016
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Long-term Study to Evaluate the Maintenance of Efficacy and Safety of 1 to 3 mg/Day of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 4/25/2016
Click here to add this to my saved trials
Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Updated: 4/25/2016
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Long-term Study to Evaluate the Maintenance of Efficacy and Safety of 1 to 3 mg/Day of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 4/25/2016
Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Updated: 4/25/2016
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Long-term Study to Evaluate the Maintenance of Efficacy and Safety of 1 to 3 mg/Day of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 4/25/2016
Click here to add this to my saved trials
Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Updated: 4/25/2016
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Long-term Study to Evaluate the Maintenance of Efficacy and Safety of 1 to 3 mg/Day of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 4/25/2016
Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Updated: 4/25/2016
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Long-term Study to Evaluate the Maintenance of Efficacy and Safety of 1 to 3 mg/Day of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 4/25/2016
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Updated: 4/26/2016
A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 and 200 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Status: Enrolling
Updated: 4/26/2016
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Updated: 4/26/2016
A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 and 200 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Status: Enrolling
Updated: 4/26/2016
Click here to add this to my saved trials